Dr. Shannon Boye
Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.
Related Articles
Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients
Alcon’s Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.
50 years of ophthalmology: What changed the game (Part 2)
Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.
LIGHTHOUSE study of ATSN-201 expanded to continuous phase 1/2/3 trial following FDA feedback
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Heat, Smog, Mold: How the Environment Can Affect Your Patients’ Eyes
Heat, mold, smog, and other environmental factors can take a toll on eye health.
Proper implementation essential for AI in medicine
CLEVELAND — While effective use of AI in medicine relies on technology, physicians must prioritize learning to properly implement it, according to a speaker at…
Week in Review: Physical Activity and Visual Improvements in Glaucoma, Global AMD-Related Vision Impairment, Effect of Environmental Factors on RRD
Increasing physical activity may help visual outcomes in patients with glaucoma, vision impairment due to age-related macular degeneration (AMD) continues to be a problem worldwide,…
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
This cohort study conducted in Ontario, Canada, evaluates the risk of developing neovascular age-related macular degeneration associated with the use of glucagon-like peptide-1 receptor agonists…
Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients
Alcon’s Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.
Declaration of a Pandemic, 5 Years Later
This Viewpoint discusses what progress and challenges have been illuminated by worldwide response to the COVID-19 pandemic from the public health, research, and clinical care…
Newsletter Signup
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.